Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

8.80
Delayed Data
As of May 27
 +0.14 / +1.62%
Today’s Change
5.18
Today|||52-Week Range
11.26
-15.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues3.8M8.8M15.0M20.1M
 
 
 
 
 
Cost of Goods Sold1.3M2.0M3.7M4.5M
 
 
 
 
 
Depreciation And Amortization56.3K58.1K52.5K62.4K
 
 
 
 
 
 
Operating ExpensesGross Income2.4M6.8M11.3M15.6M
 
 
 
 
 
General Expenses18.6M32.8M65.3M100.8M
 
 
 
 
 
Research And Development4.5M13.6M43.2M72.0M
 
 
 
 
 
Total Operating Expenses20.0M34.8M69.1M105.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.1M-26.1M-54.0M-85.2M
 
 
 
 
 
Extraordinary Credit0.00250.0K0.000.00
 
 
Extraordinary Charge-17.0M0.000.000.00
 
 
Interest Expense On Debt2.0M2.7M0.000.00
 
 
 
Other Expenses3.0K34.5K-213.5K95.7K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.1M-28.4M-54.2M-85.1M
 
 
 
 
 
Net Income-35.1M-28.4M-54.2M-85.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS91.6M127.6M149.7M173.2M
 
 
 
 
 
Shares To Calculate EPS Diluted91.6M127.6M149.7M173.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.22-$0.36-$0.49
 
 
 
 
 
EPS Diluted-$0.38-$0.22-$0.36-$0.49